Poolbeg Pharma (POLB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

2.70p
   
  • Change Today:
      0.050p
  • 52 Week High: 13.00p
  • 52 Week Low: 2.40p
  • Currency: UK Pounds
  • Shares Issued: 697.20m
  • Volume: 319,661
  • Market Cap: £18.82m

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth Not Available

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio Not Available
Price Book Ratio
42.24% below the market average42.24% below the market average42.24% below the market average42.24% below the market average42.24% below the market average
24.32% above the sector average24.32% above the sector average24.32% above the sector average24.32% above the sector average24.32% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
85.96% below the market average85.96% below the market average85.96% below the market average85.96% below the market average85.96% below the market average
95.56% below the sector average95.56% below the sector average95.56% below the sector average95.56% below the sector average95.56% below the sector average
Price Chg 3m
79.6% below the market average79.6% below the market average79.6% below the market average79.6% below the market average79.6% below the market average
73.33% below the sector average73.33% below the sector average73.33% below the sector average73.33% below the sector average73.33% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
65.73% below the market average65.73% below the market average65.73% below the market average65.73% below the market average65.73% below the market average
90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average
Momentum 20
29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average
41.46% below the sector average41.46% below the sector average41.46% below the sector average41.46% below the sector average41.46% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin Not Available
ROCE
68.65% below the market average68.65% below the market average68.65% below the market average68.65% below the market average68.65% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
58.92% below the market average58.92% below the market average58.92% below the market average58.92% below the market average58.92% below the market average
31.82% below the sector average31.82% below the sector average31.82% below the sector average31.82% below the sector average31.82% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover Not Available
Operating Profit Loss
78.59% below the market average78.59% below the market average78.59% below the market average78.59% below the market average78.59% below the market average
40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
35.42% below the market average35.42% below the market average35.42% below the market average35.42% below the market average35.42% below the market average
2.44% above the sector average2.44% above the sector average2.44% above the sector average2.44% above the sector average2.44% above the sector average
Cash
64.76% below the market average64.76% below the market average64.76% below the market average64.76% below the market average64.76% below the market average
58.14% below the sector average58.14% below the sector average58.14% below the sector average58.14% below the sector average58.14% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y
5.23% above the market average5.23% above the market average5.23% above the market average5.23% above the market average5.23% above the market average
16.13% above the sector average16.13% above the sector average16.13% above the sector average16.13% above the sector average16.13% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Poolbeg Pharma Market Data

Currency UK Pounds
Share Price 2.70p
Change Today 0.050p
% Change 1.89 %
52 Week High 13.00p
52 Week Low 2.40p
Volume 319,661
Shares Issued 697.20m
Market Cap £18.82m

Poolbeg Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
50.72% below the market average50.72% below the market average50.72% below the market average50.72% below the market average50.72% below the market average
11.63% below the sector average11.63% below the sector average11.63% below the sector average11.63% below the sector average11.63% below the sector average
Price Trend
39.68% below the market average39.68% below the market average39.68% below the market average39.68% below the market average39.68% below the market average
51.11% below the sector average51.11% below the sector average51.11% below the sector average51.11% below the sector average51.11% below the sector average
Income Not Available
Growth Not Available

Poolbeg Pharma Dividends

No dividends found

Trades for 01-Aug-2025

Time Volume / Share Price
16:24 36,623 @ 2.71p
15:10 2,450 @ 2.80p
15:09 1 @ 2.64p
12:14 150,000 @ 2.62p
11:41 14,291 @ 2.64p

Poolbeg Pharma Key Personnel

CEO Jeremy Skillington
CFO Ian O’Connel

Top of Page